Ayesha Ayesha

Ayesha Ayesha


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
HUHammad Ullah
Hammad Ullah
AAAyesha Ayesha
Ayesha Ayesha
Kannan RR RengasamyKannan RR Rengasamy
Kannan RR Rengasamy
AMAlessandro Di Minno
Alessandro Di Minno
RSRoberto Sacchi
Roberto Sacchi
Maria DagliaMaria Daglia
Maria Daglia
Depression is a common and serious health issue affecting around 280 million people around the world. Suicidal ideation more frequently occurs in people with moderate to severe depression. Psychotherapy and pharmacological drugs are the mainstay of available treatment options for depressive disorders. However, pharmacological options do not offer complete cure, especially in moderate to severe depression, and are often seen with a range of adverse events. S-adenosyl methionine (SAMe) supplementation has been widely studied, and an impressive collection of literature published over the last few decades suggests its antidepressant efficacy. Probiotics have gained significant attention due to their wide array of clinical uses, and multiple studies have explored the link between probiotic species and mood disorders. Gut dysbiosis is one of the risk factors in depression by inducing systemic inflammation accompanied by an imbalance in neurotransmitter production. Thus, concomitant administration of probiotics may be an effective treatment strategy in patients with depressed mood, particularly in resistant cases, as these can aid in dysbiosis, possibly resulting in the attenuation of systemic inflammatory processes and the improvement of the therapeutic efficacy of SAMe. The current review highlights the therapeutic roles of SAMe and probiotics in depression, their mechanistic targets, and their possible synergistic effects and may help in the development of food supplements consisting of a combination of SAMe and probiotics with new dosage forms that may improve their bioavailability.

21 September 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
HUHammad Ullah
Hammad Ullah
CECristina Esposito
Cristina Esposito
RPRoberto Piccinocchi
Roberto Piccinocchi
LLLorenza Francesca De Lellis
Lorenza Francesca De Lellis
CSCristina Santarcangelo
Cristina Santarcangelo
Maria DagliaMaria Daglia
Maria Daglia
Dietary fiber exerts beneficial effects on human health reducing the risk factors of metabolic related diseases such as hyperglycemia, insulin resistance, and hypercholesterolemia. The aim of this study is to demonstrate the efficacy of a food supplement based on brewer’s spent grain (BSG) extract in the reduction of postprandial glycemia and insulinemia in normoglycemic subjects. BSG was chemically characterized, revealing the presence of resistant starch (14.64 g/100 g), arabinoxylans (7.50 g/100 g), β-glucans (1.92 g/100 g) and other soluble fibers (6.43 g/100 g), and bioaccessible ferulic acid (91.3 mg/100 g). For the clinical study, 40 normoglycemic subjects were randomized into two groups, 1 and 2 (n = 20), for a cross-over clinical design and received either BSG extract-based food supplement or placebo. Postprandial blood glucose values were significantly lower than corresponding values in the placebo group after 90 and 120 min, while at the baseline and in the first 60 min, the two glycemic curves overlapped substantially. This improved clinical outcome was corroborated by significant reductions in postprandial insulinemia. None of the subjects reported adverse effects. This study showed that the tested BSG extract-based food supplement improves glucose metabolism and insulinemic response in normoglycemic subjects with at most a mild insulin resistance.

19 November 2022 in Cancers
Verified
Journal Article
Open access
PDF file
MDMarco Dacrema
Marco Dacrema
AAArif Ali
Arif Ali
HUHammad Ullah
Hammad Ullah
AAAyesha Ayesha
Ayesha Ayesha
AMAlessandro Di Minno
Alessandro Di Minno
Maria DagliaMaria Daglia
Maria Daglia
Colorectal cancer (CRC) is the second most frequent cause of cancer-related mortality among all types of malignancies. Sedentary lifestyles, obesity, smoking, red and processed meat, low-fiber diets, inflammatory bowel disease, and gut dysbiosis are the most important risk factors associated with CRC pathogenesis. Alterations in gut microbiota are positively correlated with colorectal carcinogenesis, as these can dysregulate the immune response, alter the gut’s metabolic profile, modify the molecular processes in colonocytes, and initiate mutagenesis. Changes in the daily diet, and the addition of plant-based nutraceuticals, have the ability to modulate the composition and functionality of the gut microbiota, maintaining gut homeostasis and regulating host immune and inflammatory responses. Spices are one of the fundamental components of the human diet that are used for their bioactive properties (i.e., antimicrobial, antioxidant, and anti-inflammatory effects) and these exert beneficial effects on health, improving digestion and showing anti-inflammatory, immunomodulatory, and glucose- and cholesterol-lowering activities, as well as possessing properties that affect cognition and mood. The anti-inflammatory and immunomodulatory properties of spices could be useful in the prevention of various types of cancers that affect the digestive system. This review is designed to summarize the reciprocal interactions between dietary spices and the gut microbiota, and highlight the impact of dietary spices and their bioactive compounds on colorectal carcinogenesis by targeting the gut microbiota.

1 March 2025 in Insights-Journal of Health and Rehabilitation
Verified
Journal Article
Open access
PDF file
AAAyesha Ayesha
Ayesha Ayesha
NHNoor Ul Hadi
Noor Ul Hadi
Background: Mitral stenosis is a progressive valvular disorder commonly associated with rheumatic heart disease, particularly in low- and middle-income regions. Left atrial (LA) thrombus is a serious complication of mitral stenosis, increasing the risk of thromboembolic events such as stroke. While echocardiography remains the cornerstone of diagnosis, the prevalence and clinical associations of LA thrombus remain underexplored in regional populations, necessitating focused investigations to guide risk assessment and therapeutic strategies. Objective: To determine the frequency of left atrial thrombus in patients diagnosed with mitral stenosis and assess its association with comorbid conditions. Methods: A cross-sectional study was conducted at the Department of Cardiology, Mardan Medical Complex, from April to October 2024. One hundred patients aged 18–70 years with echocardiographically confirmed mitral stenosis (mitral valve area <1.5 cm²) were included using purposive sampling. Patients with mitral regurgitation, aortic valve disease, prior mitral interventions, or on anticoagulation therapy were excluded. LA thrombus was diagnosed through transthoracic echocardiography by detecting spontaneous echo contrast with dynamic, smoke-like patterns in the LA cavity and appendage. Data were analyzed using SPSS v21. Associations with comorbidities were assessed using chi-square and Fisher’s exact tests. Results: Among 100 patients, 49 (49.0%) were male and 51 (51.0%) female, with a mean age of 43.7±13.4 years and mean BMI of 25.9±2.3 kg/m². LA thrombus was identified in 19 (19.0%) patients. Significant associations were observed with diabetes (63.2% vs. 14.8%, p<0.001), hypertension (78.9% vs. 7.4%, p<0.001), and smoking (73.7% vs. 11.1%, p<0.001). Thrombus was more frequent in patients with BMI 25–29.9 kg/m² (68.4%). Conclusion: LA thrombus was prevalent in nearly one-fifth of mitral stenosis patients, particularly among those with metabolic and lifestyle-related comorbidities. Routine echocardiographic screening and integrated management of modifiable risk factors are essential to reduce thromboembolic complications.